Featured Webinars

Date Type Event Name Role Location
Jul 09, 2020 ACG LA – Healthcare Investing and M&A Outlook Learn More Sponsor Live Webinar

Please join Adam Abramowitz as he moderates this ACG LA Healthcare Panel on July 9.  He’ll be joined by seasoned private equity investors and executives leading dynamic and growing healthcare businesses.



Steve Rodgers, Managing Director, Morgan Stanley Private Equity

Jay Kim, CFO, Carbon Health

Daniel Brinkenhoff, Managing Director, Centre Partners

Brad Hively, CEO of The Oncology Institute of Hope and Innovation


Register Here:


Jun 26, 2020 Intrepid Clinic – Healthcare Opportunities in Diagnostics Learn More Host Replay

Join Intrepid bankers Adam Abramowitz and Kyle Berkman for our next Intrepid Clinic: Opportunities in Diagnostics Webinar. The pandemic has generated a clarion call highlighting the importance of diagnostics. While many labs have faced near-term challenges, innovative technological advances are creating exciting opportunities across various diagnostics segments from point-of-care solutions to specialty and genetic testing. What areas will investors and strategic buyers target coming out of this pandemic? With leaders from different vantage points of the diagnostics ecosystem, our panel will discuss the latest industry trends and which sectors are poised for growth.

Date: Friday, June 26,2020
Time: 10 a.m. PST / 1 p.m. EST
Duration: 1 hour

Panelists include:

Scott Garrett
Operating Partner, Water Street

Aaron Elliott
Chief Executive Officer, Ambry Genetics

Raymond Kelly
Vice President, Eurofins Scientific



Jun 11, 2020 ACG LA State of M&A – Investing in the Time of COVID-19 Learn More Sponsor Live Webinar

Join Intrepid senior banker Gary Rabishaw, Managing Director, as he moderates a Webinar panel on the current state of M&A.

Thursday, June 11, 2020 | 4-5 p.m. PST

To register, click here.


Industry peers from the private equity community will discuss their thoughts on what lies ahead.

  • How have they pivoted or doubled down on their investment strategies to stay ahead of the curve?
  • What have they done to adapt during these uncertain times to ensure the stability of their portfolio companies?
  • What unique opportunities will present themselves with this upheaval in the M&A market and how best to position for it?

The seasoned PE panelists are all experienced investors who have dealt with market disruptions before and they plan to address these and other pertinent questions as we all prepare for deal making post COVID-19.


May 28, 2020 - Aug 01, 2020 Intrepid Analyst Recruitment Series Learn More Host Live Webinar

While our team unfortunately could not visit universities this spring as originally planned, the recruitment of bright Analysts and Summer Analysts remains core to supporting our continued growth as a firm. In lieu of such trips, we are hosting virtual information sessions to offer interested students a glimpse into the life of an Analyst working at Intrepid.

Featured Webinar presenters include:

Should you be unable to attend, we had our current Analysts produce a short video about their Intrepid experience. View at your own risk–forgive our quarantine hair styles!

Watch the video to learn more and meet our analyst class.

May 27, 2020 ACG OC – Distressed M&A Webinar Learn More Sponsor Live Webinar

Opportunities, Risks, and Positioning in the Aftermath of COVID-19

As we move past the immediate task of reopening businesses following the initial post-COVID-19 tidal wave, many businesses and investors will focus on long term opportunities and challenges. Join our Head of Strategic Relationships, Rick Chance, as he and a panel of experts discuss the risks, opportunities, and positioning of deals.

ACG Orange County Webinar | Wednesday, May 27th, 2 – 3 p.m.


May 15, 2020 Medicate: Healthcare Opportunities Beyond the Crisis Learn More Host Live Webinar

What conversations are going on in healthcare boardrooms right now? How will the COVID-19 crisis impact healthcare dealmaking?  What sectors will private equity investors and strategic buyers continue to target?  What will they avoid?  How will key healthcare stakeholders re-evaluate their M&A strategies?  Join us on Friday, May 15th, 2020 for an exclusive video panel discussion with highly regarded healthcare dealmakers for real-time, in-depth perspectives.

Before we hear from healthcare executives on the front lines of M&A and investing, we’ll hear from Andreas Dirnagl, MUFG’s Head of Global Healthcare Research, for an update on the economic impact of COVID-19 across the healthcare ecosystem.

Date: Friday, May 15, 2020
Time: 10 a.m. PST / 1 p.m. EST
Duration: 1 hour

Opening Remarks & Moderators
image-22 image-48
Adam Abramowitz
Managing Director, Intrepid
Jonathan Bluth
Director, Intrepid
Healthcare Market Observations 

Andreas J. Dirnagl
Managing Director, MUFG Healthcare

image-46 image-47

Jeff Bailet, MD
President & CEO, Altais

Jamey Edwards
CEO, Cloudbreak

image-44 image-40
Mehran Ahmed
Principal, Webster Equity
Beth Everett
Managing Director, MUFG Healthcare


May 06, 2020 CSQ Speaker Series – “The State of Finance” Learn More Sponsor Live Webinar

As markets go through historic volatility due to the COVID-19 pandemic, business leaders need the best and timeliest information from top experts. That’s why we’ve enlisted California State Treasurer Fiona Ma and some of the sharpest minds in finance for a virtual private conversation on how these unprecedented financial markets have impacted everything from M&A and restructuring to navigating a worsened housing crisis—and how businesses can work with government programs to carve a path forward.

Intrepid Chairman, Jim Freedman will be a featured panelist.

Join us on May 6th at 11 AM – 12 PM PST (2PM – 3PM EST) for a 45-min panel followed by a 15-min Q&A.

May 05, 2020 How Healthcare Executives Are Reacting to Coronavirus Learn More Host Conference

Insights From Intrepid’s Medicate Event: How Are Healthcare Executives Reacting to Coronavirus?

During our recent Medicate Intrepid event, we discussed how California’s top healthcare executives are responding to the COVID-19 coronavirus and how it is affecting their businesses, employees and clients. Leaders in healthcare staffing, urgent care, orthopedics, autism, dental and more shared several important observations and recommendations, including:

Many companies are taking swift actions to manage or contain the virus’ spread:

  • Nearly all companies assembled HR and operational leaders to develop contingency plans for interacting with possibly infected patients and managing workforce shortages
  • Several executives are deploying tests of work-at-home systems to resolve potential continuity issues well in advance of the possibility of broader quarantines
  • Many companies have banned all non-essential travel and attendance of large conferences

Several provider groups are taking immediate precautions:

  • A therapy staffing business is working closely with each of its SNF clients to ensure their traveling therapists are not a conduit for virus transmission
  • Some physician scheduling teams are contacting upcoming patients to request that they cancel in the event of any flu-like symptoms or international travel
  • Some outpatient surgery groups are postponing elective procedures, regardless of the patient’s situation, until further notice
  • One provider of home-based services was already evaluating liability exposure for workers’ comp cases if any of their providers contract COVID-19 in a patient’s home

As a result, several businesses are experiencing and documenting business interruption “coronavirus addbacks”:

  • Some companies are already seeing supply chain disruptions and learning how many of their apparently US-based suppliers rely upon Chinese-manufactured inputs
  • One of the companies has a satellite facility in proximity of another clinic where a patient was diagnosed, which led to their landlord temporarily closing the building
  • Businesses that have historically relied upon a beneficial lift from cash-paying Asian tourists, like infertility and oncology, have seen decreases as these patients are unable to travel internationally

At the same time, several industry sectors are poised for substantial gains during this period, which they hope to sustain long-term:

  • US-based dental labs are seeing a massive increase in volume from dentists who previously sought lower-cost Chinese fabrications
  • Urgent care chains are seeing substantial volume increases with patients presenting with what they fear is coronavirus, but are in fact a much wider variety of traditional ailments
  • Diagnostic labs are experiencing an uptick in testing volume to rule in/out respiratory conditions with symptoms similar to COVID-19
  • Telemedicine technology platforms have seen a substantial increase in new customer in-bound calls, as the benefits of diagnosing patients remotely are becoming more apparent

And, most consistently, everyone is educating their employees on the essential importance of more vigilant hand washing.

1 2 3 4 5 6 7 8